Back
Immuron 10K Form
Sell
49
IMRN
Immuron
Last Price:
2.51
Seasonality Move:
48.95%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IMRN News And Ratings
See the #1 stock for the next 7 days that we like better than IMRN
IMRN Financial Statistics
Sales & Book Value
| Annual Sales: | $1.21M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.10 |
| Price / Book: | 1.2 |
Profitability
| EPS (TTM): | -0.44810 |
|---|---|
| Net Income (TTM): | $-2.56M |
| Gross Margin: | $880.8K |
| Return on Equity: | -19.48% |
| Return on Assets: | -17.51% |
Immuron Earnings Forecast
Key Immuron Financial Ratios
- The Gross Profit Margin over the past 9 years for IMRN is 72.54%.
- The Selling, General & Administrative Expenses for IMRN have been equal to 281.38% of Gross Profit Margin.
- The Research & Development expenses have been 143.63% of Revenue.
- The Interest Expense is -0.25% of Operating Income.
- The Net Earning history of IMRN is -209.81% of Total Revenues.
- Per Share Earnings over the last 9 years have been positive in 4 years.
Immuron Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IMRN |
| CUSIP: | 45254U |
| Website: | immuron.com.au |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 8.52 |
| Quick Ratio: | 7.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |